SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-028120
Filing Date
2016-11-08
Accepted
2016-11-08 08:16:17
Documents
55
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q eigr-10q_20160930.htm 10-Q 1474002
2 EX-10.1 eigr-ex101_217.htm EX-10.1 80353
3 EX-10.2 eigr-ex102_216.htm EX-10.2 207477
4 EX-31.1 eigr-ex311_7.htm EX-31.1 17193
5 EX-31.2 eigr-ex312_8.htm EX-31.2 17252
6 EX-32.1 eigr-ex321_6.htm EX-32.1 5460
  Complete submission text file 0001564590-16-028120.txt   5243214

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT eigr-20160930.xml EX-101.INS 838931
8 XBRL TAXONOMY EXTENSION SCHEMA eigr-20160930.xsd EX-101.SCH 46244
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE eigr-20160930_cal.xml EX-101.CAL 29292
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eigr-20160930_def.xml EX-101.DEF 183675
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE eigr-20160930_lab.xml EX-101.LAB 351301
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eigr-20160930_pre.xml EX-101.PRE 278303
Mailing Address 350 CAMBRIDGE AVE SUITE 350 PALO ALTO CA 94306
Business Address 350 CAMBRIDGE AVE SUITE 350 PALO ALTO CA 94306 650-279-9845
Eiger BioPharmaceuticals, Inc. (Filer) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36183 | Film No.: 161980030
SIC: 2836 Biological Products, (No Diagnostic Substances)